Effect of the pituitary adenylate cyclase-activating polypeptide on the autophagic activation observed in in vitro and in vivo models of Parkinson's disease

Biochimica Et Biophysica Acta
Asma Lamine-AjiliA Fournier

Abstract

Parkinson's disease (PD) is a neurodegenerative disorder that leads to destruction of the midbrain dopaminergic (DA) neurons. This phenomenon is related to apoptosis and its activation can be blocked by the pituitary adenylate cyclase-activating polypeptide (PACAP). Growing evidence indicates that autophagy, a self-degradation activity that cleans up the cell, is induced during the course of neurodegenerative diseases. However, the role of autophagy in the pathogenesis of neuronal disorders is yet poorly understood and the potential ability of PACAP to modulate the related autophagic activation has never been significantly investigated. Hence, we explored the putative autophagy-modulating properties of PACAP in in vitro and in vivo models of PD, using the neurotoxic agents 1-methyl-4-phenylpyridinium (MPP(+)) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), respectively, to trigger alterations of DA neurons. In both models, following the toxin exposure, PACAP reduced the autophagic activity as evaluated by the production of LC3 II, the modulation of the p62 protein levels, and the formation of autophagic vacuoles. The ability of PACAP to inhibit autophagy was also observed in an in vitro cell assay by the blocking of th...Continue Reading

References

Jan 1, 1990·Alzheimer Disease and Associated Disorders·M E Mahler, J L Cummings
Jun 13, 1998·American Journal of Human Genetics·W D Parker, R H Swerdlow
Apr 25, 2002·Proceedings of the National Academy of Sciences of the United States of America·David VaudryBruno J Gonzalez
May 25, 2002·The European Journal of Neuroscience·D VaudryB J Gonzalez
Dec 20, 2003·Biochemical and Biophysical Research Communications·Tamotsu Yoshimori
Feb 21, 2006·Antioxidants & Redox Signaling·Roberta KiffinAna Maria Cuervo
May 3, 2006·Proceedings of the National Academy of Sciences of the United States of America·Hirokazu OhtakiSeiji Shioda
Apr 3, 2010·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Qian Yang, Zixu Mao
Jul 24, 2010·Journal of Neurochemistry·Daniele CartelliGraziella Cappelletti
Aug 18, 2010·The Journal of Cell Biology·Salvatore J CherraCharleen T Chu
Aug 27, 2010·Journal of Pineal Research·Chutikorn NopparatPiyarat Govitrapong
Oct 21, 2010·Physiological Reviews·Brinda RavikumarDavid C Rubinsztein
Feb 26, 2011·Current Pharmaceutical Design·Tommy SeabornDavid Vaudry
Dec 23, 2011·The Biochemical Journal·Jisun LeeJianhua Zhang
Mar 31, 2012·Journal of Molecular Neuroscience : MN·Yuki Kambe, Atsuro Miyata
Apr 5, 2012·Cold Spring Harbor Perspectives in Medicine·Melinda A Lynch-DayDaniel J Klionsky
Sep 4, 2012·International Journal of Molecular Sciences·Andrea TamasPeter Bukovics
Sep 11, 2012·Journal of Applied Physiology·Dean L KelloggJohn M Johnson
Feb 5, 2013·Acta Pharmacologica Sinica·Warren E HochfeldDavid C Rubinsztein
Nov 23, 2013·Parkinsonism & Related Disorders·Junghyun LimYoung J Oh
Nov 23, 2013·International Immunopharmacology·Daniela S ArroyoPablo Iribarren
Dec 12, 2013·Neurochemical Research·Chutikorn NopparatPiyarat Govitrapong
Feb 5, 2014·Redox Biology·Samantha GiordanoJianhua Zhang
Feb 12, 2014·Antioxidants & Redox Signaling·Rodrigo Portes UreshinoSoraya Soubhi Smaili
Jun 28, 2014·Biochimica Et Biophysica Acta·Kai-Yvonne ShiversMaria E Figueiredo-Pereira
Jul 30, 2014·Frontiers in Cellular Neuroscience·Apostolia Fragkouli, Epaminondas Doxakis
Jan 23, 2015·Neuron·Alicia M Pickrell, Richard J Youle
Mar 17, 2015·Neurobiology of Disease·Kenneth Hensley, Marni E Harris-White
Apr 7, 2015·Seminars in Cell & Developmental Biology·Marta Martinez-Vicente

❮ Previous
Next ❯

Citations

Feb 24, 2019·Reviews in the Neurosciences·Ava NasrolahiJavad Mahmoudi
Jun 9, 2017·BioMed Research International·Elisabetta CatalaniDavide Cervia
Mar 26, 2021·Frontiers in Aging Neuroscience·Yanan ZhengLimin Shi
May 20, 2021·Neuropsychiatric Disease and Treatment·Zhen-Nian ZhangJing-Si Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Parkinson's Disease & Autophagy

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis